OPIANT

Serial Number 97975168
Registration 6919901
700

Registration Progress

Application Filed
May 19, 2022
Under Examination
Sep 27, 2022
Approved for Publication
Aug 2, 2022
Published for Opposition
Aug 2, 2022
Registered
Dec 6, 2022

Trademark Image

OPIANT

Basic Information

Serial Number
97975168
Registration Number
6919901
Filing Date
May 19, 2022
Registration Date
December 6, 2022
Published for Opposition
August 2, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 6, 2022
Registration
Registered
Classes
042

Rights Holder

INDIVIOR INC.

03
Address
10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, VA 23235

Ownership History

Opiant Pharmaceuticals, Inc.

Original Applicant
03
Santa Monica, CA

Opiant Pharmaceuticals, Inc.

Owner at Publication
03
Santa Monica, CA

Opiant Pharmaceuticals, Inc.

Original Registrant
03
Santa Monica, CA

INDIVIOR INC.

New Owner After Registration #1
03
NORTH CHESTERFIELD, VA

Legal Representation

Attorney
Shauna M Wertheim

USPTO Deadlines

Next Deadline
1077 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221206)
Due Date
December 06, 2028
Grace Period Ends
June 06, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Sep 18, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 18, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 18, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 18, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 18, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 21, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 6, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 6, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 3, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 2, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 28, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 10, 2022 IUAF S USE AMENDMENT FILED Loading...
Oct 28, 2022 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Oct 10, 2022 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Oct 24, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 10, 2022 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Oct 10, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 27, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 2, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 2, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 13, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 24, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 24, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
May 25, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 23, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical drug development services; pharmaceutical research services; development of pharmaceutical preparations and medicines for the treatment of neurological and psychiatric diseases and disorders relating to drug and chemical addictions, drug overdoses and eating disorders
First Use Anywhere: 20160600
First Use in Commerce: 20160600

Classification

International Classes
042